Close
Patheon
Flexible Biomanufacturing Solutions Information Sheet
Biologics
Thursday, August 04, 2016

Biopharmaceutical companies are facing more and more challenges when developing new large molecule products. There are an increasing number of complex molecules in the biologic pipeline as therapeutic targets narrow to orphan indications and specialized medicines. And with the market growing double the rate of the small molecule market, there are increasing numbers of biologics competing to be first to market for these smaller therapeutic populations. Advances in bioprocesses and capabilities, along with the focus on smaller, niche populations, has led to a shift in the types of capacity the market demands. These challenges are only compounded by inaccuracies in product forecasting. There is a solution: Patheon’s Flexible Biomanufacturing Solutions.

 

Please complete the short form below to download this asset.

Connect

We look forward to learning about your specific needs, please contact us.